Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples